Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M DeAngelis

Showing results (451-460 of 512) with videos related to

Pageof 52
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium StudyTimothy F Cloughesy, Patrick Y Wen, H Ian Robins, et al.
Journal of Neuro-Oncology|October 13, 2006
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiformeMorris D Groves, Vinay K Puduvalli, Susan M Chang, et al.
Neuro-Oncology Advances|November 25, 2020
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02Huanwen Chen, John Kuhn, Kathleen R Lamborn, et al.
Neuro-Oncology|September 22, 2016
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trialsEdward K Avila, Marc Chamberlain, David Schiff, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogensJun Xu, Charles W Saunders, Ping Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphomaLauren E Abrey, Tracy T Batchelor, Andrés J M Ferreri, et al.
Neuro-Oncology|February 13, 2010
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapyJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Neuro-Oncology|June 28, 2020
Clinical trial of proton craniospinal irradiation for leptomeningeal metastasesT Jonathan Yang, Neil A Wijetunga, Josh Yamada, et al.
Sustainability|April 12, 2021
Social Factors Key to Landscape-Scale Coastal Restoration: Lessons Learned from Three U.S. Case StudiesBryan M DeAngelis, Ariana E Sutton-Grier, Allison Colden, et al.
International Journal of Environmental Research and Public Health|July 24, 2021
Pseudoexfoliation and Cataract Syndrome Associated with Genetic and Epidemiological Factors in a Mayan Cohort of GuatemalaPatrice M Hicks, Elizabeth Au, William Self, et al.
Pageof 52

Showing results (451-460 of 512) with videos related to

Sort By:
Pageof 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium StudyTimothy F Cloughesy, Patrick Y Wen, H Ian Robins, et al.
Journal of Neuro-Oncology|October 13, 2006
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiformeMorris D Groves, Vinay K Puduvalli, Susan M Chang, et al.
Neuro-Oncology Advances|November 25, 2020
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02Huanwen Chen, John Kuhn, Kathleen R Lamborn, et al.
Neuro-Oncology|September 22, 2016
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trialsEdward K Avila, Marc Chamberlain, David Schiff, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogensJun Xu, Charles W Saunders, Ping Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphomaLauren E Abrey, Tracy T Batchelor, Andrés J M Ferreri, et al.
Neuro-Oncology|February 13, 2010
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapyJeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Neuro-Oncology|June 28, 2020
Clinical trial of proton craniospinal irradiation for leptomeningeal metastasesT Jonathan Yang, Neil A Wijetunga, Josh Yamada, et al.
Sustainability|April 12, 2021
Social Factors Key to Landscape-Scale Coastal Restoration: Lessons Learned from Three U.S. Case StudiesBryan M DeAngelis, Ariana E Sutton-Grier, Allison Colden, et al.
International Journal of Environmental Research and Public Health|July 24, 2021
Pseudoexfoliation and Cataract Syndrome Associated with Genetic and Epidemiological Factors in a Mayan Cohort of GuatemalaPatrice M Hicks, Elizabeth Au, William Self, et al.
Pageof 52